- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 08.04. | Syra Health Corp - 8-K, Current Report | 4 | SEC Filings | ||
| 01.04. | Syra Health announces voluntary delisting from Nasdaq | 4 | Seeking Alpha | ||
| 01.04. | Syra Health to delist from Nasdaq Capital Market | 1 | Investing.com | ||
| SYRA HEALTH Aktie jetzt für 0€ handeln | |||||
| 01.04. | Syra Health kündigt Rückzug vom NASDAQ Capital Market an | 2 | Investing.com Deutsch | ||
| 01.04. | Syra Health Announces Voluntary Delisting from the Nasdaq Capital Market | 66 | PR Newswire | CARMEL, Ind., April 1, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering... ► Artikel lesen | |
| 13.03. | Syra Health sichert Vertragsverlängerung im Wert von 660.000 US-Dollar | 1 | Investing.com Deutsch | ||
| 13.03. | Syra Health secures $660,000 population health contract extension | 1 | Seeking Alpha | ||
| 11.03. | Syra Health Corp - 8-K, Current Report | 2 | SEC Filings | ||
| 11.03. | Syra Health Corp - 10-K, Annual Report | 1 | SEC Filings | ||
| 11.03. | Syra Health Announces Full-Year Revenue of $8.0 Million, Up 45% YoY | 200 | PR Newswire | 2024 Population Health Revenue Acceleration to 132% YoY
Q4 2024 Net Losses Cut Nearly in Half Compared to Q4 2023, Highlighting Major Efficiency Gains
Continued... ► Artikel lesen | |
| 11.03. | Syra Health GAAP EPS of -$0.50, revenue of $7.98M | 1 | Seeking Alpha | ||
| 25.02. | Syra Health secures $450K contract extension in Tennessee | 2 | Investing.com | ||
| 13.02. | Syra Health sichert sich neuen Vertrag für Schulungen im Bereich psychische Gesundheit | 2 | Investing.com Deutsch | ||
| 24.01. | Syra Health files for $75M mixed securities shelf | 1 | Seeking Alpha | ||
| 17.01. | Syra Health Corp - 8-K, Current Report | - | SEC Filings | ||
| 07.01. | Why Is Syra Health Stock Surging Today? | 1 | Benzinga.com | ||
| 07.01. | Syra Health secures contracts in education, healthcare sectors | 1 | Investing.com | ||
| 07.01. | Syra Health sichert sich Verträge im Bildungs- und Gesundheitssektor | 1 | Investing.com Deutsch | ||
| 29.10.24 | Syra Health Corp - 10-Q, Quarterly Report | 3 | SEC Filings | ||
| 29.10.24 | Syra Health Corp - 8-K, Current Report | 1 | SEC Filings |
Seite:
1 2 Weiter >>
26 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SERNOVA BIOTHERAPEUTICS | 0,127 | -3,79 % | Sernova Aktie: Positives Umsatzwachstum gemeldet! | Das Biotechnologieunternehmen erweitert sein Führungsteam, sichert Finanzierungen und erhält FDA-Freigabe für klinische Studien zur Behandlung von Hypothyreose. Sernova Biotherapeutics, ehemals Sernova... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,642 | -0,47 % | Atossa Therapeutics, Inc.: Atossa Therapeutics Announces Issuance of U.S. Patent No. 12,275,684, Further Strengthening (Z)-endoxifen Portfolio | SEATTLE, April 22, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines for breast... ► Artikel lesen | |
| PING AN HEALTHCARE | 0,804 | 0,00 % | Ping An Healthcare and Technology Company Limited: Ping An Health Reports 25.8% Year-on-Year Revenue Growth in Q1 2025, with Profitability Accelerating | Revenue and Profit Surge, Driven by "AI + Health Care" Value Empowerment
SHANGHAI and HONG KONG, April 24, 2025 /PRNewswire/ -- Ping An Healthcare and Technology... ► Artikel lesen | |
| MOUNTAIN VALLEY MD | 0,013 | 0,00 % | Mountain Valley MD Holdings Inc: Mountain Valley hopes for continued growth in 2025 | ||
| CO-DIAGNOSTICS | 0,320 | +1,91 % | Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results | SALT LAKE CITY, March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the... ► Artikel lesen | |
| CYTOSORBENTS | 1,060 | +4,54 % | CytoSorbents Gains $1.7M Via NJEDA Tax Credit Sale To Fund Strategic Growth | ||
| VERU | 0,468 | -3,70 % | Veru Aktie: Bedeutet das eine Neuausrichtung? | Die Veru-Aktie verliert weiter an Wert, doch Analysten bleiben optimistisch aufgrund vielversprechender Medikamentenentwicklungen. Wird der Tiefpunkt bald erreicht? Die Veru-Aktie setzt ihre Abwärtsspirale... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 7,050 | -100,00 % | Tempest Therapeutics: Tempest Receives Orphan Drug Designation from the FDA for TPST-1495 to Treat Patients with FAP | BRISBANE, Calif., April 21, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated therapeutics... ► Artikel lesen | |
| VOLITIONRX | 0,482 | 0,00 % | VOLITIONRX LTD - 8-K, Current Report | ||
| EKSO BIONICS | 0,405 | +7,14 % | Ekso Bionics Holdings, Inc.: Bionic P&O Chosen as First Distributor of Ekso Indego Personal Within the Orthotics & Prosthetics Industry | ||
| IMUNON | 0,770 | -1,91 % | Imunon, Inc.: IMUNON Announces IMNN-001 Abstract Accepted for Oral Presentation at 2025 ASCO Annual Meeting | ||
| BEYOND AIR | 0,193 | +4,89 % | Beyond Air: NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism | The FDA designation marks a significant milestone in the development of a novel treatment for a rare neurodevelopmental disorder Plan to initiate first-in-human U.S. clinical trials of lead drug candidate... ► Artikel lesen | |
| AVINGER | 0,340 | -6,08 % | Avinger, Inc.: Avinger Reports Third Quarter 2024 Results | Lower Operating Cost Profile Drives Improved Productivity, Increased Gross Margin REDWOOD CITY, CA / ACCESSWIRE / November 7, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company... ► Artikel lesen | |
| NOVACYT | 0,473 | +4,53 % | Novacyt legt Termin für Finanzergebnisse 2024 fest | ||
| AROVELLA THERAPEUTICS | 0,049 | +2,08 % | AROVELLA THERAPEUTICS LIMITED: Notification regarding unquoted securities - ALA |
Das Unternehmen SYRA HEALTH CORP kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,105 Euro und damit +0,48 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SYRA HEALTH CORP finden Sie auf Wallstreet Online.
